CDC researchers are being forced to skip a pivotal conference on infectious disease this week due to the government shutdown, ...
The Congressional Budget Office says exemptions for orphan drugs as part of Medicare price negotiations will cost taxpayers ...
The DOJ says that Kaiser systematically altered patients’ medical records to make them appear sicker and boost its revenue.
Patients with an aggressive form of breast cancer will likely have new treatment options after AstraZeneca and Gilead ...
At a major cancer conference, Merck rolled out some showstoppers — data on drugs on which its business future may depend.
Noubar Afeyan tells the STAT Summit that political moves to replace facts with opinions won't stop with mRNA vaccines. "It’s ...
The upheaval at the Food and Drug Administration appears to be taking a toll on the pharmaceutical industry, according to a ...
The WHO announced that the last Ebola patient in Congo’s latest outbreak was discharged over the weekend and no new cases ...
BERLIN — In June, Amgen reported that an experimental drug had hit the main goal of a gastric cancer study, improving overall ...
Mark Sendak was getting tired of seeing the toil of so many colleagues go to waste. At Duke University, he was part of a team ...
From STAT’s Adam Feuerstein: Let’s start with Replimune, which said this morning the Food and Drug Administration will review ...
Safeguarding biodiversity is not simply an environmental concern but a foundational element of preventive and clinical care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback